President Donald Trump is considering moving marijuana from Schedule I to Schedule III of the federal Controlled Substances Act, a shift that would classify the drug as less dangerous and loosen long-standing restrictions, the Wall Street Journal reported, citing people familiar with the deliberations. The idea was discussed at a $1 million-per-plate fundraiser held earlier this month at Trump’s golf club in Bedminster, New Jersey. Attendees included Kim Rivers, chief executive of cannabis producer Trulieve, who encouraged the president to pursue the change and expand medical research, the report said. White House spokeswoman Abigail Jackson confirmed that the administration is reviewing all policy and legal implications but said no final decision has been made. Reclassifying cannabis would allow companies to claim federal tax deductions, facilitate clinical studies and simplify interstate commerce, potentially boosting a multibillion-dollar industry. The consideration revives a rescheduling process initiated under the previous administration but left unresolved when President Biden left office.